Skip to main content

IO Biotech, Inc.

IOBTDelisted Jun 8, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001865494

IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding IO Biotech, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of IOBT: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders20200
Shares26.2M23.6M−2.59M (−9.9%)
Value$30.7M$24.8M−$5.87M (−19.1%)

New holders (5)

Institutions that held IO Biotech, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to IOBT in Q3 2024
InstitutionSharesValue% of portfolio
Acadian Asset Management LLC60,650$63.0K0.00%
Two Sigma Investments, LP30,000$31.5K0.00%
HRT Financial LP26,646$27.0K0.00%
Virtu Financial LLC17,954$19.0K0.00%
Advisor Group Holdings, Inc.230$2420.00%

Sold out (5)

Institutions that held IO Biotech, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of IOBT in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Armistice Capital, LLC1,545,000$1.81M
FMR LLC314,600$368.1K
Citadel Advisors LLC86,894$101.7K
XTX Topco Ltd26,555$31.1K
Redwood Wealth Management Group, LLC4,166$4.87K